TheraSonic appoints Geraldine Le Duc as chairwoman of its strategic committee

We’re proud to announce the appointment of Geraldine Le Duc as the new Chairwoman of Therasonic’s Strategic Committee. Geraldine brings over more than a decade of leadership in biotech and medtech innovation, notably as CEO and co-founder of NH TherAguix. Her experience guiding deep-tech startups from early research to clinical milestones makes her a perfect fit to support Therasonic’s next phase of growth. We are excited to work alongside Geraldine as we accelerate our mission to deliver cutting-edge therapeutic solutions.

Therasonic to participate at the Annual Symposium on Therapeutic Ultrasound at Taipei, Taiwan

We are thrilled to announce that TheraSonic will be participating in the Annual International Symposium on Therapeutic Ultrasound organised by the International Society for Therapeutic Ultrasound (ISTU). This major event will take place from the 19th to the 22nd of September in Taipei, Taiwan. We are excited to share our latest research and innovations with the therapeutic ultrasound community.

TheraSonic participates to Robotique Medicale Made In France Conference

TheraSonic will be present at the Robotique Medicale Made In France conference on October 9 in Montpellier. This not-to-be-missed event brings together the major players in French medical robotics, and we are honoured to be taking part. In the afternoon, we will have the opportunity to present our innovative project during a pitch. Come and find out how TheraSonic is revolutionising the field of ultrasound therapy with cutting-edge robotic solutions.

TheraSonic raises preseed round

TheraSonic proudly announces a fundraising of 1 million euros to finance the development of its robotic medical device designed to improve drug delivery in the brain through the use of focused ultrasound. This fundraising is led by the European venture studio M2care, created on the initiative of Merieux Developpement, specialized in healthtech. Gustave Roussy Transfert also enters the capital of TheraSonic to enable access to unique clinical expertise.

Therasonic selected to pitch Oncology Upward Investment

TheraSonic has been selected to pitch at Oncology Upward Investment event organized by Matwin and Angels Sante in Bordeaux during Meet2Win convention.

TheraSonic will participate to Saclay Spring50

The Spring50 is a highly anticipated annual gathering that brings together the most promising startups in the Paris-Saclay ecosystem. This year’s event will focus on the latest advancements in various sectors, including healthcare, technology, and sustainability. TheraSonic’s participation in this event underscores its commitment to driving innovation and making a meaningful impact in the field of ultrasound therapy.